Business news

    LBT Innovations (ASX:LBT) Inks $700,000 Deal with NovaCina for APAS Technology

    Article Image

    Australian medical tech company LBT Innovations secured a contract with NovaCina, a Perth-based contract development and manufacturing organisation, for its APAS Independence instrument paired with APAS PharmaQC software.

    The deal encompasses a five-year package, including annual software licenses, maintenance, and support services, totalling over $700,000.

    Delivery and installation of the APAS instrument at NovaCina's manufacturing facility are scheduled for June.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa